Cerebellin 3 (CBLN3) is a critical synaptic organizer in the cerebellum, playing a significant role in the development and function of this brain region. As a member of the Cerebellin protein family, it is predominantly expressed in the central nervous system and contributes to the precise formation of synapses, which are essential for neuronal communication. The expression of CBLN3 is tightly regulated by multiple factors to ensure proper cerebellar circuitry. Understanding how to induce the expression of CBLN3 could provide valuable insights into the mechanisms governing cerebellar development and synaptic plasticity. While the direct pathways of CBLN3 activation are complex and not fully elucidated, certain chemicals have been identified that could potentially increase its expression indirectly through various cellular mechanisms.
Research into the molecular pathways that control gene expression has highlighted a number of chemicals that could serve as activators of CBLN3 transcription. For instance, retinoic acid, a metabolite of Vitamin A, is known for its role in neurodevelopment and could potentially enhance CBLN3 expression by engaging with retinoic acid receptors that bind to DNA response elements in gene promoters. Another compound, forskolin, is recognized for its capacity to raise intracellular cyclic AMP (cAMP) levels, which in turn can activate protein kinase A (PKA) and lead to the phosphorylation of transcription factors such as CREB. These phosphorylated transcription factors may bind to the promoter region of the CBLN3 gene, initiating transcription. Similarly, beta-estradiol could exert its effect by binding to estrogen receptors, which then interact with estrogen response elements on the CBLN3 gene promoter, facilitating transcription. Additionally, the regulation of chromatin structure plays a pivotal role in gene expression, with agents like sodium butyrate and valproic acid, known histone deacetylase inhibitors, leading to a more relaxed chromatin conformation that can enhance the transcription of genes like CBLN3. These examples represent a fraction of the potential chemical activators that could be explored for their role in the upregulation of CBLN3, shedding light on the intricate regulation of gene expression in the cerebellum.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid may upregulate CBLN3 expression by activating nuclear retinoic acid receptors that bind to retinoic acid response elements in neuronal gene promoters. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin could stimulate CBLN3 transcription by elevating intracellular cAMP, leading to the phosphorylation of transcription factors like CREB, which may bind to the CBLN3 promoter region. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-Estradiol may increase CBLN3 expression by engaging estrogen receptors that interact with estrogen response elements on the CBLN3 gene promoter, promoting gene transcription in cerebellar neurons. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride could stimulate the expression of CBLN3 through the inhibition of GSK-3, leading to the activation of transcription factors that promote gene transcription associated with synaptic function. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate may upregulate CBLN3 by inhibiting histone deacetylases, resulting in a more relaxed chromatin structure around the CBLN3 gene, facilitating transcriptional activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP could induce CBLN3 expression by serving as a membrane-permeable cAMP analog, activating PKA, and leading to the enhanced transcription of genes involved in synapse formation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid may induce CBLN3 expression through histone deacetylase inhibition, resulting in hyperacetylation of histones near the CBLN3 gene promoter and an increase in gene transcription. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $312.00 | 9 | |
Fluoxetine could stimulate CBLN3 expression indirectly by increasing serotonin levels, which may enhance neurotrophic signaling pathways and lead to the upregulation of genes related to neuroplasticity. | ||||||
Tianeptine | 66981-73-5 | sc-213044 sc-213044A | 10 mg 50 mg | $250.00 $422.00 | ||
Tianeptine may stimulate CBLN3 expression by altering glutamatergic neurotransmission, potentially resulting in the activation of transcriptional mechanisms that increase synaptic protein expression. | ||||||
Potassium Chloride | 7447-40-7 | sc-203207 sc-203207A sc-203207B sc-203207C | 500 g 2 kg 5 kg 10 kg | $25.00 $56.00 $104.00 $183.00 | 5 | |
Potassium Chloride could induce CBLN3 expression via neuronal depolarization, which triggers calcium influx and activates calcium-dependent signaling pathways leading to the transcription of synaptic genes. |